Federal lawmakers expressed surprise at the lack of regulatory oversight over medical uses of radiation at hearings in the U.S. Congress today. While everyone in attendance agreed that the current regulatory environment needs fixing, the thorny question is how to go about doing it.
Congress surprised at lack of medical radiation oversight
Feb 25, 2010
Latest in Radiation Oncology/Therapy
ASTRO: Timing key to adding immunotherapy to chemoradiation
October 1, 2024
ASTRO: Black patients voice distrust in medical research
September 30, 2024
ASTRO: IMRT and proton therapy equally effective for prostate cancer
September 30, 2024